Literature DB >> 17435591

Wilson disease: description of 282 patients evaluated over 3 decades.

Arun B Taly1, S Meenakshi-Sundaram, Sanjib Sinha, H S Swamy, G R Arunodaya.   

Abstract

The clinical manifestations of Wilson disease (WD) are varied and challenging. We conducted the current study to present the phenotypic characteristics and follow-up for a large cohort of patients with WD. We reviewed the medical records of 282 cases of WD (male:female ratio, 196:86) for clinical features, investigations, treatment, and outcome data. The clinical presentations were as follows: hepatic, 42 (14.9%); hepato-neurologic, 10 (3.5%); neurologic, 195 (69.1%); pure psychiatric, 7 (2.4%); osseomuscular, 6 (2.1%); and "presymptomatic," 15 (5.3%). Mean age was 15.9 years. Presymptomatic patients and those with the hepatic form of WD were younger and patients with osseomuscular and psychiatric forms were older than neurologic patients. The mean duration of illness at the time of diagnosis was 28 months. Predominant neurologic features were as follows: parkinsonism, 62.3%; dystonia, 35.4%; cerebellar, 28%; pyramidal signs, 16%; chorea, 9%; athetosis, 2.2%; myoclonus, 3.4%; and behavioral abnormalities, 16%. Kayser-Fleischer (KF) rings were seen as follows: neurologic patients, 100%; hepatic patients, 86%; and presymptomatic patients, 59%. Positive family history was noted in 47% and consanguinity in 54%. Patients born of consanguineous parents had an earlier age of onset and shorter duration of illness before presentation. Serum ceruloplasmin was decreased in 93% and 24-hour urinary copper excretion was increased in 70% of patients. Neuroimaging (computed tomography/magnetic resonance imaging) and electrophysiologic abnormalities were seen in many patients. Overall, 195 patients were on D-penicillamine therapy and 182 on zinc sulphate. Follow-up data, available for 225 patients, for a mean duration of 46 months, revealed improvement in 176, no change in 20, and deterioration in 6. Twenty-three patients died. To conclude, despite increased awareness and recognition and significant inroads into therapeutic frontiers, follow-up remains poor in developing countries and a return to previous level of functioning is not universal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435591     DOI: 10.1097/MD.0b013e318045a00e

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  56 in total

Review 1.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

2.  Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.

Authors:  A Moores; Susan Fox; Anthony Lang; Gideon M Hirschfield
Journal:  Can J Gastroenterol       Date:  2012-06       Impact factor: 3.522

3.  Wilson's disease: A review of what we have learned.

Authors:  Kryssia Isabel Rodriguez-Castro; Francisco Javier Hevia-Urrutia; Giacomo Carlo Sturniolo
Journal:  World J Hepatol       Date:  2015-12-18

4.  P wave dispersion is prolonged in patients with Wilson's disease.

Authors:  Nurcan Arat; Sabite Kacar; Zehra Golbasi; Meral Akdogan; Yeliz Sokmen; Sedef Kuran; Ramazan Idilman
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 5.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

6.  Presentation of Epilepsy in a Patient with Wilson's Disease and Developmental Venous Anomaly (Venous Angioma) in the Brain.

Authors:  Ammar Alobaidy; Faisal Alazri; P C Jacob; Jamila H Al-Kalbani
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

Review 7.  Protecting the mitochondrial powerhouse.

Authors:  Morten Scheibye-Knudsen; Evandro F Fang; Deborah L Croteau; David M Wilson; Vilhelm A Bohr
Journal:  Trends Cell Biol       Date:  2014-12-11       Impact factor: 20.808

Review 8.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

9.  Wilson's Disease in Bangladeshi Children: Analysis of 100 Cases.

Authors:  Md Rukunuzzaman
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2015-06-29

10.  Do cytokines have any role in Wilson's disease?

Authors:  M K Goyal; S Sinha; S A Patil; V Jayalekshmy; A B Taly
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.